<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang SA</submitter><funding>HHS | NIH | National Institute of General Medical Sciences</funding><funding>Welch Foundation</funding><funding>NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>24794-24801</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7547251</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>117(40)</volume><pubmed_abstract>The structure of lincomycin A consists of the unusual eight-carbon thiosugar core methyllincosamide (MTL) decorated with a pendent &lt;i>N&lt;/i>-methylprolinyl moiety. Previous studies on MTL biosynthesis have suggested GDP-ᴅ-&lt;i>erythro&lt;/i>-α-ᴅ-&lt;i>gluco&lt;/i>-octose and GDP-ᴅ-α-ᴅ-lincosamide as key intermediates in the pathway. However, the enzyme-catalyzed reactions resulting in the conversion of GDP-ᴅ-&lt;i>erythro&lt;/i>-α-ᴅ-&lt;i>gluco&lt;/i>-octose to GDP-ᴅ-α-ᴅ-lincosamide have not yet been elucidated. Herein, a biosynthetic subpathway involving the activities of four enzymes-LmbM, LmbL, CcbZ, and CcbS (the LmbZ and LmbS equivalents in the closely related celesticetin pathway)-is reported. These enzymes catalyze the previously unknown biosynthetic steps including 6-epimerization, 6,8-dehydration, 4-epim</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>Studies of lincosamide formation complete the biosynthetic pathway for lincomycin A.</pubmed_title><pmcid>PMC7547251</pmcid><funding_grant_id>GM035906</funding_grant_id><funding_grant_id>R37 GM035906</funding_grant_id><funding_grant_id>S10 OD021508</funding_grant_id><funding_grant_id>R01 GM035906</funding_grant_id><funding_grant_id>F-1511</funding_grant_id><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Wang SA</pubmed_authors><pubmed_authors>Liu HW</pubmed_authors><pubmed_authors>Sasaki E</pubmed_authors><pubmed_authors>Ushimaru R</pubmed_authors><pubmed_authors>Lin CI</pubmed_authors></additional><is_claimable>false</is_claimable><name>Studies of lincosamide formation complete the biosynthetic pathway for lincomycin A.</name><description>The structure of lincomycin A consists of the unusual eight-carbon thiosugar core methyllincosamide (MTL) decorated with a pendent &lt;i>N&lt;/i>-methylprolinyl moiety. Previous studies on MTL biosynthesis have suggested GDP-ᴅ-&lt;i>erythro&lt;/i>-α-ᴅ-&lt;i>gluco&lt;/i>-octose and GDP-ᴅ-α-ᴅ-lincosamide as key intermediates in the pathway. However, the enzyme-catalyzed reactions resulting in the conversion of GDP-ᴅ-&lt;i>erythro&lt;/i>-α-ᴅ-&lt;i>gluco&lt;/i>-octose to GDP-ᴅ-α-ᴅ-lincosamide have not yet been elucidated. Herein, a biosynthetic subpathway involving the activities of four enzymes-LmbM, LmbL, CcbZ, and CcbS (the LmbZ and LmbS equivalents in the closely related celesticetin pathway)-is reported. These enzymes catalyze the previously unknown biosynthetic steps including 6-epimerization, 6,8-dehydration, 4-epim</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Oct</publication><modification>2025-04-18T13:42:04.582Z</modification><creation>2025-04-06T23:28:07.066Z</creation></dates><accession>S-EPMC7547251</accession><cross_references><pubmed>32958639</pubmed><doi>10.1073/pnas.2009306117</doi></cross_references></HashMap>